Varaico: Literature-Extracted Genetic Variants

Gene:SETX
Variant:p.L389S
Back to variants list

SETX

NM_015046.7:p.L389S

Associated Papers

Genetic commonalities between rare subtypes of ALS and CMT: insights into molecular mechanisms of neurodegeneration.

Aynaashe A et al.

Amino Acids, 2026

Genetic architecture of amyotrophic lateral sclerosis: a comprehensive review.

Yuan L et al.

Journal of Genetics and Genomics = Yi Chuan Xue Bao, 2025

Allele-specific silencing of a dominant SETX mutation in familial amyotrophic lateral sclerosis type 4.

Winkelsas A et al.

Hgg Advances, 2025

Developing a disease-specific accessible transcriptional signature as a biomarker for ataxia with oculomotor apraxia type 2.

Ngo KJ et al.

Molecular Medicine (cambridge, Mass.), 2025

40413398 (PubMed )
Supplement: 10020_2025_1257_MOESM4_ESM.xlsx › Table1_-_study_subjects_-_draft

Rare Diseases, Spotlighting Amyotrophic Lateral Sclerosis, Huntington's Disease, and Myasthenia Gravis: Insights from Landscape Analysis of Current Research.

Iyer KA et al.

Biochemistry, 2025

40169538 (PubMed )
Supplement: bi4c00722_si_001.pdf

A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis.

Arreola-Aldape CA et al.

Frontiers in Neuroscience, 2025

40589786 (PubMed )
Supplement: Table_4.xlsx › ClinVar_filtered_variants

Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study.

Itou T et al.

Journal of Neuroinflammation, 2024

Allele-specific silencing of a dominant SETX mutation in familial amyotrophic lateral sclerosis type 4.

Winkelsas A et al.

Biorxiv : the Preprint Server for Biology, 2024

ALS Identified: two-year findings from a sponsored ALS genetic testing program.

Goutman SA et al.

Annals of Clinical and Translational Neurology, 2024

39044379 (PubMed )
Supplement: ACN3-11-2201-s003.xlsx › ClinGen_VariantClassification

Senataxin: A key actor in RNA metabolism, genome integrity and neurodegeneration.

Giannini M et al.

Biochimie, 2024

Role of senataxin in R-loop-mediated neurodegeneration.

Kannan A et al.

Brain Communications, 2024

Role of Senataxin in Amyotrophic Lateral Sclerosis.

Tsui A et al.

Journal of Molecular Neuroscience : Mn, 2023

Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity.

Bennett CL et al.

Acta Neuropathologica Communications, 2023

An autopsy case of sporadic, adult-onset amyotrophic lateral sclerosis with heterozygous p.N1935S SETX gene variant.

Nakamura M et al.

Journal of Neuropathology and Experimental Neurology, 2023

Senataxin and R-loops homeostasis: multifaced implications in carcinogenesis.

Gatti V et al.

Cell Death Discovery, 2023

Human senataxin is a bona fide R-loop resolving enzyme and transcription termination factor.

Hasanova Z et al.

Nucleic Acids Research, 2023

Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants.

McCann EP et al.

Journal of Neuromuscular Diseases, 2023

37638449 (PubMed )
Supplement: jnd-10-jnd230148-s001.xlsx › variant_list

Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS.

McGoldrick P et al.

Frontiers in Cellular Neuroscience, 2023

Altered SYNJ2BP-mediated mitochondrial-ER contacts in motor neuron disease.

Pourshafie N et al.

Neurobiology of Disease, 2022

35907632 (PubMed )
Supplement: NIHMS1828562-supplement-MMC4.xlsx › Sheet1

Mutation in senataxin alters the mechanism of R-loop resolution in amyotrophic lateral sclerosis 4.

Kannan A et al.

Brain : a Journal of Neurology, 2022

Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4.

Campisi L et al.

Nature, 2022

Modelling amyotrophic lateral sclerosis in rodents.

Todd TW et al.

Nature Reviews. Neuroscience, 2022

R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy.

Cuartas J et al.

Frontiers in Cellular Neuroscience, 2022

Biological networks and complexity in early-onset motor neuron diseases.

Butchbach MER et al.

Frontiers in Neurology, 2022

De novo pathogenic variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathy.

Hadjinicolaou A et al.

Acta Neuropathologica Communications, 2021

SUMOylated Senataxin functions in genome stability, RNA degradation, and stress granule disassembly, and is linked with inherited ataxia and motor neuron disease.

Bennett CL et al.

Molecular Genetics & Genomic Medicine, 2021

Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives.

Bonifacino T et al.

International Journal of Molecular Sciences, 2021

Unusual electrophysiological findings in a Chinese ALS 4 family with SETX-L389S mutation: a three-year follow-up.

Lei L et al.

Journal of Neurology, 2021

Destination Amyotrophic Lateral Sclerosis.

Keon M et al.

Frontiers in Neurology, 2021

33854469 (PubMed )
Supplement: Table_1.XLSX › Genes

The expanding genetic landscape of hereditary motor neuropathies.

Beijer D et al.

Brain : a Journal of Neurology, 2020

Molecular and Cellular Mechanisms Affected in ALS.

Le Gall L et al.

Journal of Personalized Medicine, 2020

[A case of motor and sensory polyneuropathy and respiratory failure with novel heterozygous mutation of the senataxin gene].

Kitao R et al.

Rinsho Shinkeigaku = Clinical Neurology, 2020

Tight expression regulation of senataxin, linked to motor neuron disease and ataxia, is required to avert cell-cycle block and nucleolus disassembly.

Bennett CL et al.

Heliyon, 2020

Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4.

Grunseich C et al.

Annals of Neurology, 2020

Splicing and neurodegeneration: Insights and mechanisms.

Nik S et al.

Wiley Interdisciplinary Reviews. Rna, 2019

R-Loops in Motor Neuron Diseases.

Perego MGL et al.

Molecular Neurobiology, 2019

Genetic analysis of neurodegenerative diseases in a pathology cohort.

Blauwendraat C et al.

Neurobiology of Aging, 2019

A Novel Homozygous Variant of SETX Causes Ataxia with Oculomotor Apraxia Type 2.

Tariq H et al.

Journal of Clinical Neurology (seoul, Korea), 2018

Combined deficiency of Senataxin and DNA-PKcs causes DNA damage accumulation and neurodegeneration in spinal muscular atrophy.

Kannan A et al.

Nucleic Acids Research, 2018

Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.

Bennett CL et al.

Acta Neuropathologica, 2018

Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters.

Grunseich C et al.

Molecular Cell, 2018

Senataxin, A Novel Helicase at the Interface of RNA Transcriptome Regulation and Neurobiology: From Normal Function to Pathological Roles in Motor Neuron Disease and Cerebellar Degeneration.

Bennett CL et al.

Advances in Neurobiology, 2018

Genetics of amyotrophic lateral sclerosis.

Corcia P et al.

Revue Neurologique, 2017

High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis.

Tripolszki K et al.

Brain and Behavior, 2017

Mutation analysis of patients with neurodegenerative disorders using NeuroX array.

Ghani M et al.

Neurobiology of Aging, 2015

1–50 of 69 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."